Gupta N, Yücel YH. Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol. 2007;18:110–4.

Article  PubMed  Google Scholar 

Stewart W, Kolker A, Sharpe E, Day D, Konstas A, Hollo G, et al. Long-term progression at individual mean intraocular pressure levels in primary open-angle and exfoliative glaucoma. Eur J Ophthalmol. 2008;18:765–70.

Article  PubMed  Google Scholar 

Singh K, Shrivastava A. Intraocular pressure fluctuations: how much do they matter? Curr Opin Ophthalmol. 2009;20:84–7.

Article  PubMed  Google Scholar 

Lee DA, Higginbotham EJ. Glaucoma and its treatment: a review. Am J Health Syst Pharm. 2005;62:691–9.

Article  PubMed  Google Scholar 

Whitson JT. Glaucoma: a review of adjunctive therapy and new management strategies. Expert Opin Pharmacother. 2007;8:3237–49.

Article  PubMed  Google Scholar 

Miglior S, Bertuzzi F. Relationship between intraocular pressure and glaucoma onset and progression. Curr Opin Pharmacol. 2013;13:32–5.

Article  PubMed  Google Scholar 

Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311:1901–11.

Article  PubMed  PubMed Central  Google Scholar 

Moore D, Harris A, WuDunn D, Kheradiya N, Siesky B. Dysfunctional regulation of ocular blood flow: a risk factor for glaucoma? Clinophthalmol. 2008;2:849–61.

Google Scholar 

Dascalu AM, Stana D, Nicolae VA, Cirstoveanu C, Vancea G, Serban D, et al. Association between vascular comorbidity and glaucoma progression: a four-year observational study. Exp Ther Med. 2021;21:283.

Article  PubMed  PubMed Central  Google Scholar 

Flammer J. The vascular concept of glaucoma. Surv Ophthalmol. 1994;38:S3–6.

Article  PubMed  Google Scholar 

Caprioli J, Coleman AL. Blood pressure, perfusion pressure, and glaucoma. Am J Ophthalmol. 2010;149:704–12.

Article  PubMed  Google Scholar 

Costa VP, Arcieri ES, Harris A. Blood pressure and glaucoma. Br J Ophthalmol. 2009;93:1276–82.

Article  PubMed  Google Scholar 

Yanagi M, Kawasaki R, Wang JJ, Wong TY, Crowston J, Kiuchi Y. Vascular risk factors in glaucoma: a review. Clin Exp Ophthalmol. 2011;39:252–8.

Article  PubMed  Google Scholar 

Van Eijgen J, Melgarejo JD, Van Laeken J, Van der Pluijm C, Matheussen H, Verhaegen M, et al. The relevance of arterial blood pressure in the management of glaucoma progression: a systematic review. Am J Hypertens. 2024;37:179–98.

Article  PubMed  Google Scholar 

Lee EB, Hu W, Singh K, Wang SY. The association among blood pressure, blood pressure medications, and glaucoma in a nationwide electronic health records database. Ophthalmology. 2022;129:276–84.

Article  PubMed  Google Scholar 

Yilmaz KC, Sur Gungor S, Ciftci O, Akman A, Muderrisoglu H. Relationship between primary open angle glaucoma and blood pressure. Acta Cardiol. 2020;75:54–8.

Article  PubMed  Google Scholar 

Melgarejo JD, Eijgen JV, Wei D, Maestre GE, Al-Aswad LA, Liao C-T, et al. Effect of 24-h blood pressure dysregulations and reduced ocular perfusion pressure in open-angle glaucoma progression. J Hypertens. 2023;41:1785–92.

Article  PubMed  PubMed Central  Google Scholar 

Matuoka ML, Santos KS, Cruz NF, Kasahara N. Correlation between ocular perfusion pressure and translaminar pressure difference in glaucoma: evidence for a three-pressure disease? Eur J Ophthalmol. 2021;31:2412–7.

Article  PubMed  Google Scholar 

Ch’ng T, Chua C, Kalsom MU, Azhany Y, Gong V, Rasool A, et al. Ocular perfusion pressure and severity of glaucoma: is there a link? J Curr Glaucoma Pract. 2021;15:78.

Article  PubMed  PubMed Central  Google Scholar 

Raman P, Suliman NB, Zahari M, Kook M, Ramli N. Low nocturnal diastolic ocular perfusion pressure as a risk factor for NTG progression: a 5-year prospective study. Eye. 2018;32:1183–9.

Article  PubMed  PubMed Central  Google Scholar 

Melgarejo JD, Eijgen JV, Wei D, Maestre GE, Aswad LAA, Mena LJ, et al. PS-C12-3: Open-angle glaucomatous optic damage in relation to systemic and ocular perfusion pressure. J Hypertens. 2023;41:e218–e9.

Google Scholar 

Costa VP, Harris A, Anderson D, Stodtmeister R, Cremasco F, Kergoat H, et al. Ocular perfusion pressure in glaucoma. Acta Ophthalmol. 2014;92:e252–66.

Article  PubMed  Google Scholar 

Schuman JS. Measuring blood flow: so what? JAMA Ophthalmol. 2015;133:1052–3.

Article  PubMed  PubMed Central  Google Scholar 

Okumura N, Narimoto K, Tomooka K, Koizumi N, Tanito M. Development of bidirectional encoder representations from transformers by transfer learning for analysis of the electronic medical records of patients with glaucoma. Nippon Ganka Gakkai Zasshi. 2024;128:21–9 (in Japanese).

Google Scholar 

Charlson ME, de Moraes CG, Link A, Wells MT, Harmon G, Peterson JC, et al. Nocturnal systemic hypotension increases the risk of glaucoma progression. Ophthalmology. 2014;121:2004–12.

Article  PubMed  Google Scholar 

Melgarejo JD, Van Eijgen J, Wei D, Maestre GE, Al-Aswad LA, Liao C-T, et al. Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure. Front Cardiovasc Med. 2022;9:1024044.

Article  PubMed  PubMed Central  Google Scholar 

Werne A, Harris A, Moore D, BenZion I, Siesky B. The circadian variations in systemic blood pressure, ocular perfusion pressure, and ocular blood flow: risk factors for glaucoma? Surv Ophthalmol. 2008;53:559–67.

Article  PubMed  Google Scholar 

Tokunaga T, Kashiwagi K, Tsumura T, Taguchi K, Tsukahara S. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma. Jpn J Ophthalmol. 2004;48:380–5.

Article  PubMed  Google Scholar 

Kim JH, Rabiolo A, Morales E, Yu F, Afifi AA, Nouri-Mahdavi K, et al. Risk factors for fast visual field progression in glaucoma. Am J Ophthalmol. 2019;207:268–78.

Article  PubMed  Google Scholar 

De Moraes CGV, Juthani VJ, Liebmann JM, Teng CC, Tello C, Susanna R, et al. Risk factors for visual field progression in treated glaucoma. Arch Ophthalmol. 2011;129:562–8.

Article  PubMed  Google Scholar 

Spry P, Sparrow J, Diamond J, Harris H. Risk factors for progressive visual field loss in primary open angle glaucoma. Eye. 2005;19:643–51.

Article  PubMed  Google Scholar 

Bommakanti N, De Moraes CG, Boland MV, Myers JS, Wellik SR, Elze T, et al. Baseline age and mean deviation affect the rate of glaucomatous vision loss. J Glaucoma. 2020;29:31–8.

Article  PubMed  Google Scholar 

Konstas AG, Mantziris DA, Stewart WC. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol. 1997;115:182–5.

Article  PubMed  Google Scholar 

Konstas A, Tsatsos I, Kardasopoulos A, Bufidis T, Maskaleris G. Preoperative features of patients with exfoliation glaucoma and primary open-angle glaucoma. The AHEPA study. Acta Ophthalmol Scand. 1998;76:208–12.

Article  PubMed  Google Scholar 

Tarkkanen AH, Kivelä TT. Comparison of primary open-angle glaucoma and exfoliation glaucoma at diagnosis. Eur J Ophthalmol. 2015;25:137–9.

Article  PubMed  Google Scholar